Inside the deal: Penn spinout Verismo Therapeutics gets acquired
Penn cell therapy spinout Verismo Therapeutics has a new owner. Here's how the deal came together and why everyone is telling ...
Yahoo Finance1mon
Verismo Therapeutics Completes Merger to Accelerate Clinical Development
PHILADELPHIA, Dec. 20, 2024 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing novel KIR-CAR platform technology, today announced the completion of a merger in which ...
Yahoo Finance10d
Verismo doses first subject in Phase I trial of SynKIR-310
Verismo Therapeutics has commenced the first patient dosing in its multicentre Phase I CELESTIAL-301 trial of SynKIR-310. The subject was dosed at the Sarah Cannon Research Institute of Colorado ...
Yahoo Finance13d
Verismo Therapeutics Announces First Patient Infused in Phase 1 CELESTIAL-301 Clinical Trial of SynKIR™-310
Clinical-stage CAR T company dosed first patient for Phase 1 trial to evaluate SynKIR™-310, a new drug candidate for relapsed/refractory B cell Non-Hodgkin Lymphomas PHILADELPHIA, Jan. 10, 2025 ...